ORGANOX Trademark

Trademark Overview


On Thursday, August 25, 2022, a trademark application was filed for ORGANOX with the United States Patent and Trademark Office. The USPTO has given the ORGANOX trademark a serial number of 97564810. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 16, 2024. This trademark is owned by OrganOx Limited. The ORGANOX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Medical and veterinary preparations, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for use with organs ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for transplant organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for organs in vivo and ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; therapeutic preparations for organs, namely, perfusion preparations in the nature of pharmaceutical solutions for m...

Medical and veterinary apparatus and instruments, namely, system for use in artificial organ support; medical and veterinary apparatus and instruments for preserving organs and body parts, namely, systems for use in artificial organ support and in preserving the viability of organs for use in transplantation; medical and veterinary apparatus for perfusing organs inside or outside human or animal bodies, namely, system for use in artificial organ support; electromagnetic medical diagnostic imaging apparatus, namely, medical and veterinary apparatus for enabling functional assessment of donor transplant organs during storage and transportation; normothermic apparatus for ex vivo organs, namely, warming device for stabilizing organ temperature for medical purposes; component parts for all the aforesaid goods

Scientific research and development in the fields of maintenance, preservation, transportation and storage of organs in vivo and ex vivo; scientific research and development in relation to the perfusion of donor transplant organs; medical research services in relation to maintaining and improving the quality of organs in vivo or ex vivo; medical and pharmacological research services; product quality and safety testing, namely, conducting efficacy and toxicity testing of pharmaceuticals for others; pharmaceutical research services, namely, conducting pharmacological testing on organs and body parts in vivo or ex vivo, being testing of pharmaceuticals; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the aforesaid services
organox

General Information


Serial Number97564810
Word MarkORGANOX
Filing DateThursday, August 25, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesMedical and veterinary preparations, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for use with organs ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for transplant organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for organs in vivo and ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; therapeutic preparations for organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for the perfusion of organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; nutrition for organs ex vivo, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs, namely, perfusion fluids containing minerals, salts, vitamins, amino acids, proteins, enzymes and other beneficial formulations for organs in vivo and ex vivo; pharmaceuticals for treating organs in vivo or ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in for maintaining and improving the quality of organs in vivo or ex vivo; biological preparations for the maintenance of organs inside or outside human or animal bodies, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs
Goods and ServicesMedical and veterinary apparatus and instruments, namely, system for use in artificial organ support; medical and veterinary apparatus and instruments for preserving organs and body parts, namely, systems for use in artificial organ support and in preserving the viability of organs for use in transplantation; medical and veterinary apparatus for perfusing organs inside or outside human or animal bodies, namely, system for use in artificial organ support; electromagnetic medical diagnostic imaging apparatus, namely, medical and veterinary apparatus for enabling functional assessment of donor transplant organs during storage and transportation; normothermic apparatus for ex vivo organs, namely, warming device for stabilizing organ temperature for medical purposes; component parts for all the aforesaid goods
Goods and ServicesScientific research and development in the fields of maintenance, preservation, transportation and storage of organs in vivo and ex vivo; scientific research and development in relation to the perfusion of donor transplant organs; medical research services in relation to maintaining and improving the quality of organs in vivo or ex vivo; medical and pharmacological research services; product quality and safety testing, namely, conducting efficacy and toxicity testing of pharmaceuticals for others; pharmaceutical research services, namely, conducting pharmacological testing on organs and body parts in vivo or ex vivo, being testing of pharmaceuticals; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOrganOx Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLittlemore, Oxford OX44GA
GB

Party NameOrganOx Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLittlemore, Oxford OX44GA
GB

Trademark Events


Event DateEvent Description
Wednesday, June 28, 2023NON-FINAL ACTION WRITTEN
Monday, August 29, 2022NEW APPLICATION ENTERED
Wednesday, September 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 12, 2023ASSIGNED TO EXAMINER
Wednesday, June 28, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2023FINAL REFUSAL WRITTEN
Thursday, September 21, 2023FINAL REFUSAL E-MAILED
Thursday, September 21, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 20, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, October 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, October 27, 2023EXAMINERS AMENDMENT E-MAILED
Friday, October 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 27, 2023EXAMINER'S AMENDMENT ENTERED
Friday, October 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024SOU EXTENSION 1 FILED
Tuesday, July 16, 2024SOU EXTENSION 1 GRANTED
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED